Biogen acquires neuromuscular assets from AliveGen

By Jennie Walters | Jul 27, 2018 | 6:11 PM GMT

Biogen Inc. (NASDAQ:BIIB) said it acquired two early stage neuromuscular assets from AliveGen USA Inc. (Thousand Oaks, Calif.) and reported rising U.S. sales of spinal muscular atrophy (SMA) therapy Spinraza nusinersen in its 2Q18 earnings July